Zhongjun Wu

2.5k total citations
116 papers, 1.8k citations indexed

About

Zhongjun Wu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Zhongjun Wu has authored 116 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 47 papers in Cancer Research and 28 papers in Surgery. Recurrent topics in Zhongjun Wu's work include MicroRNA in disease regulation (29 papers), Cancer-related molecular mechanisms research (26 papers) and Organ Transplantation Techniques and Outcomes (18 papers). Zhongjun Wu is often cited by papers focused on MicroRNA in disease regulation (29 papers), Cancer-related molecular mechanisms research (26 papers) and Organ Transplantation Techniques and Outcomes (18 papers). Zhongjun Wu collaborates with scholars based in China, United States and Panama. Zhongjun Wu's co-authors include Xufu Wei, Daofeng Zheng, Tong Mou, Zuotian Huang, Chengyong Tang, Ai Shen, Junliang Pu, Rui Liu, Yunhai Luo and Guosheng Ren and has published in prestigious journals such as Hepatology, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Zhongjun Wu

112 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhongjun Wu China 24 1000 669 387 384 336 116 1.8k
Guoshan Ding China 17 903 0.9× 777 1.2× 244 0.6× 268 0.7× 229 0.7× 54 1.6k
Yongxiang Xia China 23 765 0.8× 519 0.8× 257 0.7× 494 1.3× 204 0.6× 56 1.9k
Beifang Ning China 23 1.4k 1.4× 929 1.4× 359 0.9× 223 0.6× 488 1.5× 36 2.2k
Steve F. Bronk United States 16 769 0.8× 388 0.6× 439 1.1× 207 0.5× 298 0.9× 18 1.6k
Yaojie Fu United States 21 678 0.7× 436 0.7× 469 1.2× 302 0.8× 195 0.6× 31 1.5k
Ling Yang China 16 662 0.7× 543 0.8× 413 1.1× 119 0.3× 586 1.7× 50 1.8k
Christian D. Fingas Germany 22 653 0.7× 374 0.6× 447 1.2× 191 0.5× 272 0.8× 37 1.7k
Ge‐Liang Xu China 23 661 0.7× 354 0.5× 216 0.6× 195 0.5× 215 0.6× 62 1.3k
Jian Wu China 21 956 1.0× 255 0.4× 393 1.0× 309 0.8× 245 0.7× 91 1.7k

Countries citing papers authored by Zhongjun Wu

Since Specialization
Citations

This map shows the geographic impact of Zhongjun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongjun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongjun Wu more than expected).

Fields of papers citing papers by Zhongjun Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongjun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongjun Wu. The network helps show where Zhongjun Wu may publish in the future.

Co-authorship network of co-authors of Zhongjun Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongjun Wu. A scholar is included among the top collaborators of Zhongjun Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongjun Wu. Zhongjun Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gong, Miao, et al.. (2025). Knowledge domain and frontier trends of artificial intelligence applied in solid organ transplantation: A visualization analysis. International Journal of Medical Informatics. 195. 105782–105782. 4 indexed citations
2.
Huang, Weifeng, et al.. (2025). ANGPTL4 induces Kupffer cell M2 polarization to mitigate acute rejection in liver transplantation. Scientific Reports. 15(1). 986–986. 4 indexed citations
4.
Wang, Yihua, Shanshan Li, Yunhai Luo, et al.. (2025). MAFF alleviates hepatic ischemia–reperfusion injury by regulating the CLCF1/STAT3 signaling pathway. Cellular & Molecular Biology Letters. 30(1). 39–39. 2 indexed citations
5.
Xie, Luoyingzi, Jie Gong, Zhiqiang He, et al.. (2025). A Copper‐Manganese Based Nanocomposite Induces Cuproptosis and Potentiates Anti‐Tumor Immune Responses. Small. 21(12). e2412174–e2412174. 7 indexed citations
6.
La, Zhang, Baoyong Zhou, Jun Yang, et al.. (2025). MTFR2‐Mediated Fission Drives Fatty Acid and Mitochondrial Co‐Transfer from Hepatic Stellate Cells to Tumor Cells Fueling Oncogenesis. Advanced Science. 12(23). e2416419–e2416419. 1 indexed citations
7.
Li, Shan, et al.. (2024). Diagnostic value and immune infiltration characterization of WTAP as a critical m6A regulator in liver transplantation. Hepatobiliary & pancreatic diseases international. 24(2). 138–146. 4 indexed citations
8.
Huang, Zuotian, et al.. (2024). PPM1G regulates hepatic ischemia/reperfusion injury through STING‐mediated inflammatory pathways in macrophages. Immunity Inflammation and Disease. 12(2). e1189–e1189. 6 indexed citations
9.
Yan, Ping, et al.. (2023). Establishment of a prognostic signature based on fatty acid metabolism genes in HCC associated with hepatitis B. BMC Gastroenterology. 23(1). 390–390. 3 indexed citations
10.
Cao, Zhenrui, et al.. (2023). miR-449a ameliorates acute rejection after liver transplantation via targeting procollagen-lysine1,2-oxoglutarate5-dioxygenase 1 in macrophages. American Journal of Transplantation. 23(3). 336–352. 2 indexed citations
11.
Cao, Zhenrui, et al.. (2023). HSP110 aggravates ischemia-reperfusion injury after liver transplantation by promoting NF-κB pathway. Hepatobiliary & pancreatic diseases international. 23(4). 344–352. 7 indexed citations
12.
13.
Li, Jiarui, et al.. (2022). Genomic analysis quantifies pyroptosis in the immune microenvironment of HBV-related hepatocellular carcinoma. Frontiers in Immunology. 13. 932303–932303. 3 indexed citations
15.
16.
Luo, Yunhai, et al.. (2020). Integrating transcriptomes and somatic mutations to identify RNA methylation regulators as a prognostic marker in hepatocellular carcinoma. Hepatobiliary & pancreatic diseases international. 20(1). 34–45. 2 indexed citations
17.
Shen, Ai, Daofeng Zheng, Yunhai Luo, et al.. (2019). MicroRNA-24-3p alleviates hepatic ischemia and reperfusion injury in mice through the repression of STING signaling. Biochemical and Biophysical Research Communications. 522(1). 47–52. 49 indexed citations
18.
Zhou, Zhuang, et al.. (2018). Dexmedetomidine protects hepatic cells against oxygen‐glucose deprivation/reperfusion injury via lncRNA CCAT1. Cell Biology International. 42(9). 1250–1258. 8 indexed citations
19.
Pan, Long, et al.. (2018). Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 106. 68–76. 48 indexed citations
20.
Zhang, Guoqing, et al.. (2015). [Over-expression of transcription factor 21 inhibits the proliferation and migration and promotes apoptosis of SMMC-7721 cells].. PubMed. 31(7). 884–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026